Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01005186
Other study ID # 2003CV40
Secondary ID
Status Completed
Phase Phase 4
First received October 29, 2009
Last updated January 7, 2016
Start date July 2006
Est. completion date July 2007

Study information

Verified date January 2016
Source University of Dundee
Contact n/a
Is FDA regulated No
Health authority United Kingdom: Research Ethics Committee
Study type Interventional

Clinical Trial Summary

A lifestyle intervention aimed at improving exercise levels in primary school children.


Recruitment information / eligibility

Status Completed
Enrollment 92
Est. completion date July 2007
Est. primary completion date July 2007
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 9 Years to 11 Years
Eligibility Inclusion Criteria

- Children 9-11 yrs

Exclusion Criteria:

- Children <9 yrs and >12 yrs

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Behavioral:
Eating habits, diet and exercise
Programme of change to eating habits, diet and exercise

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
University of Dundee University of St Andrews

Outcome

Type Measure Description Time frame Safety issue
Primary Can an acceptable strategy, based on social cultural factors that influence adherence to the strategy and designed for altering lifestyle associated with CV risk (ALL CHANGE) be developed for school aged children? No
Secondary Is ALL CHANGE more effective in altering lifestyle than conventional health education delivered as part of the school curriculum? No
See also
  Status Clinical Trial Phase
Completed NCT01139827 - Association Between Framingham Risk Score, hsCRP and Vascular Inflammation: Analysis With 18F-Fluorodeoxyglucose Positron Emission Tomography N/A
Recruiting NCT05767073 - LIVES: Personalized Lifestyle Intervention for Patients With Depression N/A
Completed NCT04626505 - Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition in Japan. Phase 2
Completed NCT00856882 - The Effects of Soy Protein and Isoflavones on Glycemic Control, Insulin Sensitivity and Cardiovascular Risk Factors N/A
Completed NCT04330937 - Clinical Trial on the Effectiveness of Citrolive N/A
Completed NCT01781416 - Level of Concordance Between Patients Perception and Physicians Evaluation of Cardiovascular Risk N/A
Completed NCT01475513 - Oral Contraceptives, Insulin Resistance and Cardiovascular Risk Profile in Pre-Menopausal Women Phase 4
Enrolling by invitation NCT06122961 - Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)
Completed NCT04506749 - To Evaluate the Efficacy of a Nutraceutical in Reducing Cardiovascular Risk in Healthy Subjects N/A
Completed NCT03412175 - CREATION Health Lifestyle Intervention N/A
Completed NCT02144922 - Effect of Pitavastatin on Coronary Flow Reserve in Hypertensive Patients Phase 4
Completed NCT00921752 - C2 -CORVUS Cholesterol-Control (C2) Controlled Targets for High Vascular Risk Patients Using Effective Statins (CORVUS) N/A
Completed NCT00697580 - Strength and Nutrition Outcomes for Latino Adolescents N/A
Enrolling by invitation NCT04450914 - Implementing Shared Decision Making (SDM) For Individualized CV Prevention (SDM4IP) N/A
Completed NCT01003574 - Evaluation of Cardiovascular Health Outcomes Among Survivors N/A
Not yet recruiting NCT06118281 - ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack Phase 3
Completed NCT01441323 - Strength Training and Nutrition Development for African American Youth N/A
Completed NCT01103648 - Effect of Simvastatin and Ezetimibe on Lipid and Inflammation N/A
Completed NCT01015092 - Cardiovascular Risk Evaluation and Antiretrovirals in HIV N/A
Not yet recruiting NCT05882266 - The Role of Plant-Based Omega-3 Fatty Acids and Molecular Characterisation in Individuals With Cardiovascular(CVD) Risk N/A